Companies Dominating the Metastatic Bladder Cancer Market
- Genentech, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merck & Co., Inc.
- Bristol Myers Squibb Company
- AstraZeneca PLC
- Pfizer Inc.
- Eli Lilly and Company
- Johnson & Johnson
- Novartis International AG
- Astellas Pharma Inc.
- Sanofi S.A.
Browse Key Market Insights with Data Illustration:
In the News
- Merck merged its wholly owned subsidiary Merck Development & Commercialization Inc., a US-based pharmaceutical company, with Merck Pharmaceuticals America Inc., a US-based pharmaceutical company. The merger was aimed at streamlining operations and improving efficiency.
- Merck merged its wholly owned subsidiary Merck Manufacturing Division, a US-based pharmaceutical manufacturing company, with Merck Pharmaceuticals Supply Chain, a US-based pharmaceutical supply chain company. The merger was aimed at streamlining operations and improving efficiency.